Intech Investment Management LLC Akebia Therapeutics, Inc. Transaction History
Intech Investment Management LLC
- $10 Billion
- Q4 2024
A detailed history of Intech Investment Management LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 118,209 shares of AKBA stock, worth $248,238. This represents 0.0% of its overall portfolio holdings.
Number of Shares
118,209
Previous 45,066
162.3%
Holding current value
$248,238
Previous $59,000
271.19%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AKBA
# of Institutions
127Shares Held
56.5MCall Options Held
291KPut Options Held
179K-
Black Rock Inc. New York, NY11.6MShares$24.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$22.9 Million0.0% of portfolio
-
Satter Management Co., L.P.5.75MShares$12.1 Million13.23% of portfolio
-
Geode Capital Management, LLC Boston, MA4.75MShares$9.98 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.72MShares$7.81 Million0.01% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $386M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...